Your contumelious remarks come as no surprise, however, I can...

Your contumelious remarks come as no surprise, however, I can assure you, I have absolutely no problems grasping and ingesting your schoolmasterly prose. You would know, I'm guessing, that JCR are to be responsible for the registration, manufacturing and launch of JCR-031 and they will also be responsible for the commercialisation costs. Until I am able to unearth more details on how this impacts MSB, I'm afraid I 'm not prepared to hazard a guess as to profitability.
And I'm sorry to leave you bewildered as your voluminous postings on MSB have left me in no doubt that you are NOT a holder, however, you were the one who coined the phrase "the Celgene Put" and I was idly wondering whether you would now agree that in striking the deal with MSB, Celgene were more likely trying to dissuade rivals from mounting a counter-bid for this technology? Incidentally, the strike price is $A3.82, not $A2.82.